Table 1.
Definitions of Pathological Changes of Chronic Cholecystitis.
Figure 1.
H.pylori infection in metaplastic gallbladder mucosa (oil immersion lens,×1000, red arrow indicates H.pylori).
Figure 2.
PCR products of Helicobacter specific 16s rRNA gene from gallbladder and gastric mucosa samples.
(lanes M: step-ladder marker; 1: positive control of gastric biopsy-derived H. pylori DNA; 2: negative control of gastric biopsy; 3: negative 16s rRNA gene in gallbladder; 4 and 5: negative 16s rRNA gene in gallbladder and gastric mucosa acquired from one individual patient; 6 and 7: positive 16s rRNA gene in gallbladder and gastric mucosa acquired from another individual patient).
Figure 3.
Comparison of complete sequence data of H. pylori 16s rRNA gene tested in gallbladder mucosa sample from published GenBank data: sequence ID ref|NR_044761.1|.
(nucleotides 263–695 were listed).
Figure 4.
BLAST showed H. pylori 16s rRNA gene in gallbladder and gastric mucosa from the same individual patient had completely identical sequences.
(sequence ID50661: H. pylori 16s rRNA tested in gallbladder mucosa; sequence ID50659: H. pylori 16s rRNA tested in gastric mucosa).
Table 2.
Clinical characteristics of H.pylori-positive and negative chronic cholecystitis.
Figure 5.
Metaplasia of Chronic Cholecystitis (hematoxylin-eosin stain,×100).
Figure 6.
iNOS expression in gallbladder mucosa of chronic cholecystitis with H. pylori infection (A) and without H. pylori infection (B) (×100).
Figure 7.
ROS expression in gallbladder mucosa of chronic cholecystitis with H. pylori infection (A) and without H. pylori infection (B) (×100).
Table 3.
Pathological characteristics of H.pylori-positive and negative chronic cholecystitis.